BioSpace News Archive

What can the public do to defend against the COVID-19 coronavirus? One simple answer is to ramp up humidification at home and in the workplace, if humidity levels are low.

Health Canada consulting Canadians on draft screening assessment under the Chemicals Management Plan OTTAWA , March 13, 2020 /CNW/ - The Government of Canada is committed to protecting the health of Canadians and the environment. Through the Chemicals Management Plan, the Government assesses chemicals used in Canada , and takes action on those found to be harmful to h

Effective immediately, Canadian Blood Services is suspending all buccal swabbing events across the country and encouraging the public to register online to get their swab kit delivered in the mail.

Additional Data Highlight PALISADE Study Patient Baseline Characteristics and Associated Treatment Response — and Improvements in Self-Reported Quality of Life Following Long-Term Treatment with PALFORZIA

CymaBay Therapeutics, Inc. confirmed that Engine Capital Management has nominated three candidates to stand for election to the Company’s Board of Directors at the 2020 Annual Meeting.

With coronavirus case counts climbing, New Jersey hospitals and the New Jersey Hospital Association are moving to enact no-visitor policies to protect patients, visitors and staff.

Genetic Technologies Limited announced that after the close of the ASX market on March 13, 2020, it received a determination letter from The Nasdaq Stock Market LLC indicating that it did not comply with the Listing Rule 5550 for continued listing on the Nasdaq Capital Market

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-Co

BD, issued the following statement after a White House meeting with CEOs of companies who have been involved in the effort to expand access to COVID-19 testing and test development.

Zyla Life Sciences, a commercial stage life sciences company, announced that its year end 2019 financial results will be released on March 27, 2020.